Eton Pharmaceuticals
Pharmaceutical ManufacturingIllinois, United States51-200 Employees
Eton Pharmaceuticals is an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases.
Innovative Portfolio Eton Pharmaceuticals specializes in treatments for rare diseases with recent product launches like Galzin for Wilson disease, indicating ongoing product development and a robust pipeline that can be targeted for expanding market reach and patient access solutions.
Leadership Stability The appointment of Judy Matthews as CFO reflects strategic leadership changes aimed at strengthening financial management, presenting an opportunity to offer tailored financial services or partner solutions to support their growth initiatives.
Strategic Partnerships Eton's collaboration with Key Proteo and expanded partnerships with OptimeCare highlight openness to alliances, creating potential sales opportunities in specialty pharmacy services, distribution channels, and collaborative research tools.
Market Engagement Active participation in major healthcare conferences demonstrates Eton's commitment to visibility and thought leadership, which can be leveraged to introduce innovative technology solutions or targeted marketing platforms to expand their reach.
Financial Growth With revenues between 25M-50M and recent funding of 11M, Eton is positioned for expansion and scaling, providing opportunities for sales of high-impact technology, consulting, or infrastructure solutions to support their clinical and commercial growth.
Eton Pharmaceuticals uses 8 technology products and services including GSAP, JSON-LD, TweenMax, and more. Explore Eton Pharmaceuticals's tech stack below.
| Eton Pharmaceuticals Email Formats | Percentage |
| FLast@etonpharma.com | 91% |
| LastFirst@etonpharma.com | 5% |
| Last.First@etonpharma.com | 4% |
Pharmaceutical ManufacturingIllinois, United States51-200 Employees
Eton Pharmaceuticals is an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases.
Eton Pharmaceuticals has raised a total of $11M of funding over 4 rounds. Their latest funding round was raised on Apr 01, 2021 in the amount of $11M.
Eton Pharmaceuticals's revenue is estimated to be in the range of $25M$50M
Eton Pharmaceuticals has raised a total of $11M of funding over 4 rounds. Their latest funding round was raised on Apr 01, 2021 in the amount of $11M.
Eton Pharmaceuticals's revenue is estimated to be in the range of $25M$50M